Encoded Therapeutics – Translating Next-Generation Science into ...
Sorry, your browser doesn't support embedded videos.
Encoded deciphers pivotal path with phase 1/2 gene therapy data
6 days ago · Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian …
Encoded Therapeutics' AAV Gene Therapy ETX101 Shows 78% Seizure ...
Dec 5, 2025 · SOUTH SAN FRANCISCO, Calif. – December 5, 2025 –Encoded Therapeutics delivered encouraging clinical data for its AAV gene therapy candidate, ETX101, at the
Encoded Therapeutics Reports Clinical Progress of ETX101 Gene …
Feb 13, 2025 · Collaboration agreement signed with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, for Lilly Gene Therapy to use Encoded’s novel regulatory elements.
Encoded Therapeutics Reports Clinical Progress of ... - Business Wire
Feb 13, 2025 · Encoded and Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, signed a collaboration agreement in May 2024 for Lilly Gene Therapy to use Encoded’s novel …
Encoded Therapeutics Presents Positive Interim Efficacy Data from ...
3 days ago · SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- #AES2025 --Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe …
News – Encoded Therapeutics
Encoded Therapeutics to Present Interim Phase 1/2 Clinical Data on ETX101, the First One-time Gene Therapy in Development for Dravet Syndrome, at the 2025 American Epilepsy Society Annual Meeting
Encoded lays off 29% of staff to fund Dravet gene therapy trial
Feb 13, 2025 · Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program.
Encoded Therapeutics Reports Clinical Progress of ETX101 Gene …
Feb 19, 2025 · Encoded Therapeutics is a clinical-stage biotechnology company developing AAV-based gene therapies for severe CNS disorders. Its proprietary platform combines novel AAV vector …
Encoded Therapeutics Presents Promising New Data for CNS Gene …
May 14, 2025 · About Encoded Therapeutics Encoded Therapeutics is a clinical-stage genetic medicines company developing potentially one-time, disease-modifying therapies for severe CNS …